SCHEMBL8288566

SCHEMBL8288566

COC(=O)OC[C@@H](NC(=O)OC(C)(C)C)C1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HDAC4 P56524 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ EPHX1 P07099 1/20 0.42
▸ CTSS P25774 2/20 0.41
▸ CTSK P43235 2/20 0.41
▸ GAA P10253 1/20 0.40
▸ AAK1 Q2M2I8 2/20 0.39
▸ CACNA1B Q00975 6/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA7 P43166 1/20 0.38
▸ BTK Q06187 1/20 0.38
▸ KMT2A Q03164 1/20 0.37
▸ THRB P10828 1/20 0.36
▸ CA12 O43570 1/20 0.35
▸ CA14 Q9ULX7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14073621 1.00 HDAC4 (0.42) HDAC4HDAC1HDAC6EPHX1CTSS
SCHEMBL24298159 0.87 EPHX1 (0.46) HDAC4HDAC1HDAC6EPHX1CTSS
SCHEMBL90706 0.87 EPHX1 (0.46) HDAC4HDAC1HDAC6EPHX1CTSS
SCHEMBL89503 0.87 EPHX1 (0.46) HDAC4HDAC1HDAC6EPHX1CTSS
SCHEMBL14073619 0.82 EPHX1 (0.46) HDAC4HDAC1HDAC6EPHX1CTSS
SCHEMBL3125943 0.82 EPHX1 (0.46) HDAC4HDAC1HDAC6EPHX1CTSS
SCHEMBL90608 0.82 EPHX1 (0.44) HDAC4HDAC1HDAC6EPHX1CTSS
SCHEMBL90287 0.82 EPHX1 (0.44) HDAC4HDAC1HDAC6EPHX1CTSS
SCHEMBL14509988 0.82 THRB (0.38) EPHX1CA1CA2KMT2ATHRB
SCHEMBL7905864 0.81 HDAC4 (0.39) HDAC4HDAC1HDAC6EPHX1CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1939213-B1 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORP (US) 2010-08-25 — — EP disclosed
EP-1939213-A1 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2008-07-02 — — EP disclosed
WO-2005087725-A2 NOVEL COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2005-09-22 — — WO disclosed
Send feedback